331 results on '"Lo Caputo, Sergio"'
Search Results
2. Low-wage agricultural migrant workers in Apulian Ghettos, Italy: General health conditions assessment and HIV screening
3. No association of a risk variant for severe COVID-19 with HIV protection in three cohorts of highly exposed individuals.
4. Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options—the ICONA Foundation cohort study
5. Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: Data from the ICONA cohort
6. Prevalence and genetic diversity of Blastocystis sp. among autochthonous and immigrant patients in Italy
7. Pillars of long-term antiretroviral therapy success
8. GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial
9. The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study.
10. Safety and heart rate changes in Covid-19 patients treated with Remdesivir
11. Determinants of loss to care and risk of clinical progression in PLWH who are re-engaged in care after a temporary loss
12. Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts
13. Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: data from the ICONA cohort
14. Doravirine plus Integrase Strand Transfer Inhibitors as a two-drugs treatment-switch strategy in PLWH: the real-life DORINI multicentric cohort study
15. Apulian infectious diseases network: survey on the prevalence of delta infection among chronic HBV carriers in Apulia
16. What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study
17. Impact of vaccination on electrocardiograms of hospitalized patients for Covid-19
18. Salivary miRNA Profiles in COVID-19 Patients with Different Disease Severities
19. Clinical Characteristics, Outcomes, and Risk Factors of Patients Hospitalized for COVID-19 across the Latest Pandemic Waves: Has Something Changed?
20. Real-Life Advantages and Limits of Baricitinib for the Late Treatment of Adults Hospitalized with COVID-19
21. GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomised placebo-controlled phase 2 trial (COVITAR)
22. The elderly and direct antiviral agents: Constraint or challenge?
23. Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort.
24. Marked decrease in acquired resistance to antiretrovirals in latest years in Italy
25. Monkeypox virus infection mimicking primary syphilis
26. Two cases of Monkeypox virus infection without detectable cutaneous/mucosal lesions
27. Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case–control study
28. Perceptions of U = U Among Italian Infectious Diseases Specialists: A Nationwide Survey on Providers' Attitudes Toward the Risk of HIV Transmission in Virologically Suppressed Patients
29. Management of Chronic Hepatitis B in HIV-Coinfected Patients
30. Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non-AIDS-Defining Events in a Large Cohort of HIV-Infected Patients
31. Durability of Second Antiretroviral Regimens in the Italian Cohort Naive Antiretrovirals Foundation Study and Factors Associated with Discontinuation
32. Neuropsychiatric Disorders in Pediatric Long COVID-19: A Case Series
33. Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees
34. Long-term effectiveness of rilpivirine-based single-tablet regimens in a seven-year two centers observational cohort of people living with HIV.
35. Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic
36. CD46 Genetic Variability and HIV-1 Infection Susceptibility
37. Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature
38. Specific Enfuvirtide-Associated Mutational Pathways in HIV-1 Gp41 Are Significantly Correlated with an Increase in CD4⁺ Cell Count, despite Virological Failure
39. Sex and gender differences in COVID-19: an Italian local register-based study
40. General Practitioners as partners for a shared management of chronic HIV infection: An insight into the perspectives of Italian People Living with HIV
41. Mucosal and Systemic Immune Activation Is Present in Human Immunodeficiency Virus-Exposed Seronegative Women
42. Human Immunodeficiency Virus (HIV)-Specific IgA and HIV Neutralizing Activity in the Serum of Exposed Seronegative Partners of HIV-Seropositive Persons
43. Evolutionary Analysis Identifies an MX2 Haplotype Associated with Natural Resistance to HIV-1 Infection
44. Injectable Antiretroviral Drugs: Back to the Future
45. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis
46. HIV rapid test in a community setting as a strategy to improve access to HIV testing: data from a multicentre experience in Italy
47. Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2?
48. SARS-COV-2 serological profile in healthcare professionals and a preliminary evaluation of IgG and IgA in saliva samples: a study from a southern Italy hospital.
49. Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy
50. SARS-COV-2 Serological Profile in Healthcare Professionals of a Southern Italy Hospital
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.